Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-Current Debt: 2020

  • Caribou Biosciences' Non-Current Debt was N/A to $924,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $924,000, marking a year-over-year change of. This contributed to the annual value of $924,000 for FY2020, which is N/A change from last year.
  • Latest data reveals that Caribou Biosciences reported Non-Current Debt of $924,000 as of Q4 2020.
  • In the past 5 years, Caribou Biosciences' Non-Current Debt ranged from a high of $924,000 in Q4 2020 and a low of $924,000 during Q4 2020.
  • Its 1-year average for Non-Current Debt is $924,000, with a median of $924,000 in 2020.